z-logo
open-access-imgOpen Access
IDSA Guidelines on Group A Streptococcal Pharyngitis vis-a-vis Tonsillectomy Recommendations
Author(s) -
Reginald F. Baugh
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit011
Subject(s) - medicine , pharyngitis , tonsillectomy , streptococcal infections , tonsillitis , group a , dermatology , pediatrics , intensive care medicine , surgery , immunology
TO THE EDITOR—The clinical practice guideline for tonsillectomy in children recently published as a supplement by in Otolaryngology–Head and Neck Surgery by Baugh et al [1] was incorrectly referenced regarding the tonsillectomy recommendations in the streptococcal pharyngitis 2012 update in Clinical Infectious Diseases [2]. The scope of our tonsillectomy guideline does not include adults, nor do the other 3 references listed in the Infectious Diseases Society of America guideline [1, 3–5]. The criteria identified in the article, “the rare patient whose symptomatic episodes do not diminish in frequency over time” and “for whom no alternative explanation for recurrent GAS [group A Streptococcus] pharyngitis is evident” [2] do not reflect the criteria specified in our guideline [1], the best available medical evidence, or even the other references listed [3–5]. The surgical conclusions that “tonsillectomy has been demonstrated to be beneficial only for a relatively small group of these patients” and that “any benefit can be expected to be relatively short-lived” are ambiguous, potentially misleading statements [2]. It is disappointing that these unsupported, ill-defined summary assertions were not even identified as potentially controversial (ie, judged as controversial, limited, conflicting, or in need of additional research) [2]. Our guideline, which makes clear appropriate surgical recommendations based upon the best medical evidence, has been endorsed by the American Academy of Pediatrics and is listed in their approved pediatric clinical practice guidelines and policies [1]. The evidence that would permit extrapolation of the pediatric outcomes to adults is lacking and is insufficient to justify the statements made.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom